These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 38780505)
1. Unveiling the role of the KLF4/Lnc18q22.2/ULBP3 axis in the tumorigenesis and immune escape of hepatocellular carcinoma under hypoxic condition. Wei L; He P; Tan Z; Zhao L; Lin C; Wei Z J Cell Mol Med; 2024 May; 28(10):e18411. PubMed ID: 38780505 [TBL] [Abstract][Full Text] [Related]
2. MicroRNA‑9‑5p downregulates Klf4 and influences the progression of hepatocellular carcinoma via the AKT signaling pathway. Dong X; Wang F; Xue Y; Lin Z; Song W; Yang N; Li Q Int J Mol Med; 2019 Mar; 43(3):1417-1429. PubMed ID: 30664155 [TBL] [Abstract][Full Text] [Related]
3. Dysregulated Krüppel-like factor 4 and vitamin D receptor signaling contribute to progression of hepatocellular carcinoma. Li Q; Gao Y; Jia Z; Mishra L; Guo K; Li Z; Le X; Wei D; Huang S; Xie K Gastroenterology; 2012 Sep; 143(3):799-810.e2. PubMed ID: 22677193 [TBL] [Abstract][Full Text] [Related]
4. KLF4 Suppresses the Progression of Hepatocellular Carcinoma by Reducing Tumor ATP Synthesis through Targeting the Mir-206/RICTOR Axis. Wang Y; Zuo D; Huang Z; Qiu Y; Wu Z; Liu S; Zeng Y; Qiu Z; He W; Li B; Yuan Y; Niu Y; Qiu J Int J Mol Sci; 2024 Jun; 25(13):. PubMed ID: 39000273 [TBL] [Abstract][Full Text] [Related]
5. Hypoxia-responsive lncRNA MIR155HG promotes PD-L1 expression in hepatocellular carcinoma cells by enhancing HIF-1α mRNA stability. Qiu J; Zhong F; Zhang Z; Pan B; Ye D; Zhang X; Yao Y; Luo Y; Wang X; Tang N Int Immunopharmacol; 2024 Jul; 136():112415. PubMed ID: 38850791 [TBL] [Abstract][Full Text] [Related]
6. LncRNA DGCR5 represses the development of hepatocellular carcinoma by targeting the miR-346/KLF14 axis. Wang YG; Liu J; Shi M; Chen FX J Cell Physiol; 2018 Jan; 234(1):572-580. PubMed ID: 30216442 [TBL] [Abstract][Full Text] [Related]
7. LNCAROD enhances hepatocellular carcinoma malignancy by activating glycolysis through induction of pyruvate kinase isoform PKM2. Jia G; Wang Y; Lin C; Lai S; Dai H; Wang Z; Dai L; Su H; Song Y; Zhang N; Feng Y; Tang B J Exp Clin Cancer Res; 2021 Sep; 40(1):299. PubMed ID: 34551796 [TBL] [Abstract][Full Text] [Related]
8. Loss of KLF4 and consequential downregulation of Smad7 exacerbate oncogenic TGF-β signaling in and promote progression of hepatocellular carcinoma. Sun H; Peng Z; Tang H; Xie D; Jia Z; Zhong L; Zhao S; Ma Z; Gao Y; Zeng L; Luo R; Xie K Oncogene; 2017 May; 36(21):2957-2968. PubMed ID: 28192402 [TBL] [Abstract][Full Text] [Related]
9. LncRNA Jiang J; Dong W; Zhang W; Wang Q; Wang R; Wang J; Wu H; Dong H; Zhao RC; Wang J; Li Z Discov Med; 2023 Dec; 35(179):995-1014. PubMed ID: 38058065 [TBL] [Abstract][Full Text] [Related]
10. Hypoxia-driven lncRNA CTD-2510F5.4: a potential player in hepatocellular carcinoma's prognostic stratification, cellular behavior, tumor microenvironment, and therapeutic response. Abulihaiti Z; Li W; Yang L; Zhang H; Du A; Tang N; Lu Y; Zeng J Mol Biol Rep; 2024 Aug; 51(1):905. PubMed ID: 39133347 [TBL] [Abstract][Full Text] [Related]
11. DANCR contributed to hepatocellular carcinoma malignancy via sponging miR-216a-5p and modulating KLF12. Wang J; Pu J; Zhang Y; Yao T; Luo Z; Li W; Xu G; Liu J; Wei W; Deng Y J Cell Physiol; 2019 Jun; 234(6):9408-9416. PubMed ID: 30430564 [TBL] [Abstract][Full Text] [Related]
12. Increased long noncoding RNA LASP1-AS is critical for hepatocellular carcinoma tumorigenesis via upregulating LASP1. Yin L; Chen Y; Zhou Y; Deng G; Han Y; Guo C; Li Y; Zeng S; Shen H J Cell Physiol; 2019 Aug; 234(8):13493-13509. PubMed ID: 30677131 [TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA AGAP2-AS1, functioning as a competitive endogenous RNA, upregulates ANXA11 expression by sponging miR-16-5p and promotes proliferation and metastasis in hepatocellular carcinoma. Liu Z; Wang Y; Wang L; Yao B; Sun L; Liu R; Chen T; Niu Y; Tu K; Liu Q J Exp Clin Cancer Res; 2019 May; 38(1):194. PubMed ID: 31088485 [TBL] [Abstract][Full Text] [Related]
14. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis. Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188 [TBL] [Abstract][Full Text] [Related]
15. Krüppel-like Factor 4 Blocks Hepatocellular Carcinoma Dedifferentiation and Progression through Activation of Hepatocyte Nuclear Factor-6. Sun H; Tang H; Xie D; Jia Z; Ma Z; Wei D; Mishra L; Gao Y; Zheng S; Xie K; Peng Z Clin Cancer Res; 2016 Jan; 22(2):502-12. PubMed ID: 26338995 [TBL] [Abstract][Full Text] [Related]
16. DDX17 promotes hepatocellular carcinoma progression via inhibiting Klf4 transcriptional activity. Xue Y; Jia X; Li C; Zhang K; Li L; Wu J; Yuan J; Li Q Cell Death Dis; 2019 Oct; 10(11):814. PubMed ID: 31653828 [TBL] [Abstract][Full Text] [Related]
17. Downregulation of lncRNA SBF2-AS1 inhibits hepatocellular carcinoma proliferation and migration by regulating the miR-361-5p/TGF-β1 signaling pathway. Wu YH; Yu B; Chen WX; Ai X; Zhang W; Dong W; Shao YJ Aging (Albany NY); 2021 Aug; 13(15):19260-19271. PubMed ID: 34341185 [TBL] [Abstract][Full Text] [Related]
18. LINC01419 promotes cell proliferation and metastasis in hepatocellular carcinoma by enhancing NDRG1 promoter activity. Dang H; Chen L; Tang P; Cai X; Zhang W; Zhang R; Huang A; Tang H Cell Oncol (Dordr); 2020 Oct; 43(5):931-947. PubMed ID: 32557341 [TBL] [Abstract][Full Text] [Related]
19. Long non‑coding RNA MKLN1‑AS aggravates hepatocellular carcinoma progression by functioning as a molecular sponge for miR‑654‑3p, thereby promoting hepatoma‑derived growth factor expression. Gao W; Chen X; Chi W; Xue M Int J Mol Med; 2020 Nov; 46(5):1743-1754. PubMed ID: 33000222 [TBL] [Abstract][Full Text] [Related]